Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SYNTHETIC THROMBIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kondo, LM; Wittkowsky, AK; Wiggins, BS
      Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia

      ANNALS OF PHARMACOTHERAPY
    2. Moledina, M; Chakir, M; Gandhi, PJ
      A synopsis of the clinical uses of argatroban

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    3. Vermeer, F; Vahanian, A; Fels, PW; Besse, P; Muller, E; Van de Werf, F; Fitzgerald, D; Darius, H; Puel, J; Garrigou, D; Simoons, ML
      Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    4. Kumura, T; Hino, M; Yamane, T; Tatsumi, N
      Argatroban as an anticoagulant for both hematologic and chemical tests

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    5. Onomura, M; Tsukada, H; Fukuda, K; Kodama, M; Nakamura, H; Hosokawa, M; Ohya, M; Seino, Y
      Effect of argatroban on trinitrobenzene sulfonic acid-induced colitis

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    6. Suzuki, S; Matsuo, T; Kobayashi, H; Matsuo, M; Shimamo, C; Koide, M; Sakamoto, S
      Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: Effects on inflammatory, hemostatic, and endothelium-derived parameters

      THROMBOSIS RESEARCH
    7. Leung, D; Abbenante, G; Fairlie, DP
      Protease inhibitors: Current status and future prospects

      JOURNAL OF MEDICINAL CHEMISTRY
    8. Ahmad, S; Ahsan, A; George, M; Iqbal, O; Jeske, WP; McKenna, R; Lewis, BE; Walenga, JM; Fareed, J
      Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: Potential clinical applications

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    9. Lombardi, A; De Simone, G; Nastri, F; Galdiero, S; Della Morte, R; Staiano, N; Pedone, C; Bolognesi, M; Pavone, V
      The crystal structure of alpha-thrombin-hinunorm IV complex reveals a novel specificity site recognition mode

      PROTEIN SCIENCE
    10. Ueki, Y; Matsumoto, K; Kizaki, Y; Yoshida, K; Matsunaga, Y; Yano, M; Miyake, S; Tominaga, Y; Eguchi, K
      Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: Placebo-controlled study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    11. Lyon, ME; Drobot, DW; Harding, SR; Lyon, AW
      Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) as anticoagulants for critical care clinical chemistry specimens

      CLINICA CHIMICA ACTA
    12. Sabatine, MS; Jang, IK
      Antithrombotic therapy in acute coronary syndromes

      ACTA CARDIOLOGICA
    13. PAVONE V; DESIMONE G; NASTRI F; GALDIERO S; STAIANO N; LOMBARDI A; PEDONE C
      MULTIPLE BINDING MODE OF REVERSIBLE SYNTHETIC THROMBIN INHIBITORS - ACOMPARATIVE STRUCTURAL-ANALYSIS

      Biological chemistry
    14. DESIMONE G; LOMBARDI A; GALDIERO S; NASTRI F; DELLAMORTE R; STAIANO N; PEDONE C; BOLOGNESI M; PAVONE V
      HIRUNORMS ARE TRUE HIRUDIN MIMETICS - THE CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN HIRUNORM-V COMPLEX

      Protein science
    15. JANG IK; GIUGLIANO RP; MASSEY TJ; SCHWARZ RP
      A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY

      Journal of thrombosis and thrombolysis
    16. KAISER B
      FACTOR XA VERSUS FACTOR IIA INHIBITORS

      Clinical and applied thrombosis/hemostasis
    17. PRASA D; SVENDSEN L; STURZEBECHER JJ
      INHIBITION OF THROMBIN GENERATION IN PLASMA BY INHIBITORS OF FACTOR XA

      Thrombosis and haemostasis
    18. NAWARSKAS JJ; SPINLER SA
      ADDITIONAL ANTICOAGULANT STRATEGIES FOR MANAGING HEPARIN-INDUCED THROMBOCYTOPENIA

      American journal of health-system pharmacy
    19. STRINGER SK; SELIGMANN BE
      EFFECTS OF 2 INJECTABLE ANESTHETIC AGENTS ON COAGULATION ASSAYS IN THE RAT

      Laboratory animal science
    20. KEREVEUR A; SAMAMA MM
      NEW ANTITHROMBOTIC AGENTS

      La Presse medicale
    21. RAMESH CV; JAYAKUMAR R; PUVANAKRISHNAN R
      IN-VITRO STUDIES ON A NOVEL MICELLE-FORMING PEPTIDE WITH ANTICOAGULANT ACTIVITY

      International journal of peptide & protein research
    22. CALLAS D; FAREED J
      COMPARATIVE PHARMACOLOGY OF SITE-DIRECTED ANTITHROMBIN AGENTS - IMPLICATION IN DRUG DEVELOPMENT

      Thrombosis and haemostasis
    23. KARIO K; MATSUO T; YAMADA T; MATSUO M
      INCREASED TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN UREMIC PATIENTS ON REGULAR HEMODIALYSIS

      Thrombosis and haemostasis
    24. ADANG AEP; HERMKENS PHH; LINDERS JTM; OTTENHEIJM HCJ; VANSTAVEREN CJ
      CASE-HISTORIES OF PEPTIDOMIMETICS - PROGRESSION FROM PEPTIDES TO DRUGS

      Recueil des travaux chimiques des Pays-Bas


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 12:58:17